医学微生物学和免疫学 SCIE

期刊简介预计审稿时间： 约1.0个月

Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.

MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.

The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.

The following categories of manuscripts will not be considered for publication in MMIM:

submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,

manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,

manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,

manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,

case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.

《医学微生物学和免疫学》（MMIM）发表关于传染源和宿主免疫系统之间相互关系的所有方面的重要发现。该期刊的主要重点是针对病毒、细菌、真菌和寄生虫（原生动物和蠕虫）感染的内在、先天或适应性免疫反应以及相应传染性病原体的毒力的原创研究工作。

MMIM 涵盖传染病和传染病免疫学的基础、转化和临床研究。欢迎使用细胞培养物、类器官和动物模型进行基础研究，前提是这些模型具有临床相关性并解决相关的医学问题。

该期刊还考虑有关传染病流行病学的稿件，包括病原体的出现和流行性传播以及对抗感染疗法的耐药性的发展，以及新型疫苗和其他创新预防措施。

以下类别的稿件将不考虑在 MMIM 上发表：

提交初步工作，仅提供描述性数据集而未进行机制研究或全球关注度有限的稿件，

关于现有或新型抗感染化合物的稿件，重点关注药物的药学或药理学方面，

关于现有或改良疫苗的稿件，除非它们报告了实验或临床疗效研究或提供了有关其作用方式的新免疫学信息，

关于传染病诊断的稿件，除非它们提供了解决传染病诊断的新概念待定的诊断问题，

病例报告或病例系列，除非它们嵌入在专注于抗感染免疫反应和/或病原体毒力的研究中。

《Medical Microbiology And Immunology》(医学微生物学和免疫学)编辑部通讯方式为SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。